Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So in your view it isn't ok for CTIX to tell the truth, but it is ok for anonymous sources to spread lies about the company.
The reason CTIX is divulging observations is because they are defending themselves against claims that CTIX drugs have no value, and do not work. These claims have cut the market cap of the company in half. In this case the CEO may have gotten permission from the investigator to release this information.
Is this the kind of world we should live in? Bears can say anything, but the attacked company should just stay quiet?
Nice! I like this:
"Presently, the Company is drafting a study protocol for a Phase 2/3 clinical trial on ovarian cancers."
I appreciate you bringing this up. It totally explains yesterdays action. After the PR yesterday, they shorted the stock down expecting a negative SA article in the afternoon. I thought it was strange that the Bid firmed up after 2 PM. Turns out the SA article was rejected, so the instablog article came out right after 2 PM instead. So a lot of manipulation going on. The shorters are casting an illusion here that the stock can't go up on good news. I hope this group has a difficult time covering today. Thanks!
I agree Grizzly. K is looking great at this point. Certainly sitting at around $2 makes little sense. When the PH1 trial ends and more data is revealed we should see a big move here. Hopefully we can uplist after the 10k this September. This last drop the last two days was tough, but I am really glad that Leo came through with the PR yesterday. Thanks Leo! Go CTIX!
I Agree. I bought my first CTIX shares at $1.45 on 12/17/2012. This was just after K Ph 1 started. We had no other trials. Now 3 years of great company progress (SP wise) was pretty much wiped out in one week by a group of short sellers. This is hard to believe. This proves the company needs to get off the pink sheets. NYSE MKT or Nasdaq, I don't care. I am also fine with a RS to get this done. We need to move to a real Exchange!
Glad that P Ph 2 is underway! Hopefully this helps with getting the SP moving back up where it belongs. Go CTIX!!!
Nice chart Karin! Thanks for taking the time to put that together. As you mention, the SP will eventually reflect all this great progress CTIX is making. I think what the SP has done the last week is crazy. This is what can happen on a light float stock during the summer doldrums. Like many of you, I will be a buyer next week at these ridiculous prices. Everyone have a great Sunday!
Follow the posts back.
I never said the application was closed. It should be open.
If we end up not meeting the $3 closing price alternative, we could still qualify by trading over $4 for 90 days, or having our Net tangible assets go above the $5 million mark.
Also, it is always possible the Nasdaq bends some of the rules with a higher share price.
I did say in my post that there was a chance that Nasdaq could determine we have 2 years of Operating History. No one would be happier if we uplisted in the next few days.
My question "So what are the odds the Nasdaq thinks we have 2 years of Operating History, when they have already determined we don't have 3?" was that, a question, not analysis.
What do you think the odds are? 80/20, 50/50, 20/80? I realize you do not like to speculate. IMO 50/50 at best.
I hope there was another reason we did not uplist other than price. That would be great if there was another snag that got cleared up and it allows us to uplist in short order.
After posting here for almost 2 1/2 years I am surprised some see me as setting seeds of doubt. I am one of the biggest bulls here.
Without uplisting the SP is still dirt cheap, and is a Strong buy IMO. Not expecting much more of a pullback, if any, with more news pending.
Everyone have a great day!
That is why I have doubts about us making the $3 closing price alternative.
Leo's last uplisting PR was very telling, because it means we did not meet the $2 closing price alternative (Market Value). Which means Nasdaq determined that we did not meet either of the following:
ii) net tangible assets of $5 million, or (iii) net tangible assets of $2 million and a 3 year operating history
So much for the Nasdaq having flexible/loose rules. This is exactly what I was worried about in this post from last May:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113545265
We had 4.6 million in Net tangible Assets, just shy of the the 5 million required for (ii). The Nasdaq must have determined this was not close enough.
The 4.6 million met the 2 million requirement for (iii), but the nasdaq must have determined that we did not have 3 year operating history.
One of the main requirements for the $3 closing price alternative (equity standard) is 2 years operating History. So what are the odds the Nasdaq thinks we have 2 years of Operating History, when they have already determined we don't have 3?
I guess there is the chance that the Nasdaq would consider clinical trials as operating History. K Phase 1 is 2.5 years old, so it would make the 2 years. It is also possible the Nasdaq is more flexible with their rules with SP at $3 versus $2.
While I am hoping that we uplist very soon, and make the $3 closing price alternative, I am certainly not counting on it.
The good news with that is it means no Gap today. LOL...
With this news, partnership may be right around the corner!
Makes sense that Pediatric would be a separate trial. Thanks!
Should I assume that the two trials will be a Phase 3A, with a Phase 3B following that? It would not be two phase 3 trials running at the same time, correct? Sorry if this is a dumb question. TIA.
Great News! Surprised it is not part of a corporate update.
Ok, sorry I read into your post wrong. All is good. :>)
Ellaruth makes a good point in the Instablog link below. Also, I see she upped her shares somewhere along the line from 10k to 45k. Smart girl!
Attention PolyMedix Shareholders: Brilacidin & Definsin's Are Free!
http://seekingalpha.com/instablog/21116141-ellaruth/4187445-attention-polymedix-shareholders-brilacidin-and-definsins-are-free
Glad he answered your question. Nice to see that we can expect more than one Orphan Drug designation!
Thanks for sharing this!
No, not implying anything. Just stating that some of us may have been aware of the possibility of them applying for this status.
You are 100% correct. I should have said "without additional Institutional support". :>)
While I couldn't predict this would happen, I did send an email to Leo on this exact subject (Orphan Drug Designation for ovarian cancer) earlier this year.
I asked him if he was aware that Critical Outcome Technologies, that also has a P53 drug, was able to get this Orphan drug for Ovarian cancer before even starting Phase 1 trials. I asked if they planned on filing for this anytime soon. I provided this link showing the other company getting this designation:
http://www.marketwired.com/press-release/Critical-Outcome-Technologies-Receives-Orphan-Drug-Designation-For-COTI-2-TSX%20VENTURE-COT-1921334.htm
Leo never responded. Well, not until yesterday. :>)
Way to get it done Leo!
Awesome News Eric! Thanks! Can't believe there is no PR yet!
It is pretty clear to most that for the huge potential growth here, CTIX trades like a value stock (maybe even deep value). Only a few things will eventually get CTIX to a fair valuation:
1) Time. Moving drugs forward, and time for any extra Aruda shares to be absorbed by the market.
2) Partnership. Extra money on the balance sheet and the third party verification would do wonders to the market cap.
3) Uplisting. We will never get out of this undervalued state without having Institutional support.
LR, great job on figuring that out! Thanks for explaining that institutions only are required to do a 13-F for securities traded on a national securities exchange, and it means not every institutional holding of CTIX will show up on the Nasdaq site. Means until CTIX uplists, it may take us a bit more digging at each quarter end to find any/all the institutional holdings. Thanks again for figuring this out. I appreciate it!
Thanks for clearing that up. I didn't remember seeing anything about any recent insider buys here. Good reason, there hasn't been any. Thanks LR!
How many shares has DR. Menon reestablished? Can you provide a link to this? Thanks!
Not sure how you came up with that. We have probably done about 30 million shares volume since the first of the year. 2 million shares would be closer to 7% of that, not 75%.
Were you one decimal point off in your calculation?
Markets cheer as leaders strike deal on Greece
http://money.cnn.com/2015/07/12/investing/greece-world-markets/index.html
Looks like we will see a positive day in the markets today.
Maybe CTIX will see another follow through green day. Go CTIX!!!
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
I believe this article (abstract) is from 2014, but it is the first time I have seen it. Not sure if it has ever been posted here. It mentions Kevetrin/cellceutix along with a couple of Roche drugs. Thought some here might find it interesting. Here is the link:
http://www.ingentaconnect.com/content/ben/cdt/2014/00000015/00000001/art00010?crawler=true
Nice! Nice to see P Ph2 starting soon. Looks like lots of sites:
Locations
United States, California
Cellceutix Study Center Not yet recruiting
Encino, California, United States, 91436
United States, Florida
Cellceutix Study Center Not yet recruiting
Coral Gables, Florida, United States, 33134
Cellceutix Study Center Not yet recruiting
Hialeah, Florida, United States, 33016
Cellceutix Study Center Not yet recruiting
Miami, Florida, United States, 33144
Cellceutix Study Center Not yet recruiting
Miami, Florida, United States, 33175
Cellceutix Study Center
Miami, Florida, United States, 33126
Cellceutix Study Center Not yet recruiting
Miramar, Florida, United States, 33027
Cellceutix Study Center Not yet recruiting
Tampa, Florida, United States, 33609
Cellceutix Study Center
Tampa, Florida, United States, 33618
United States, Nevada
Cellceutix Study Center Not yet recruiting
Las Vegas, Nevada, United States, 89119
Thanks for providing the link for that. I'm surprised the Nasdaq site does not reflect the purchase for that end of quarter date. Thanks!
Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
NEW YORK, July 9, 2015 /PRNewswire/ -- Rodman & Renshaw Conferences, LLC is hosting The Rodman & Renshaw Annual Global Investment Conference on September 8 through September 10, 2015 at the St. Regis Hotel in New York. More than 200 public & private companies from around the world are expected to present to an audience of over 2,000 attendees. The event will feature tracks devoted to Biotechnology/Healthcare, Metals & Mining, Technology, Cleantech and Growth. The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and daily networking opportunities. Institutional investors, venture capitalists, private equity firms, sophisticated private investors and industry executives are welcome to attend this conference.
Link: http://www.prnewswire.com/news-releases/rodman--renshaw-2015-annual-global-investment-conference-to-be-held-in-new-york-from-september-8-to-10-2015-300110562.html#sthash.On36bLYj.dpuf
I do not see CTIX in the partial list of companies in the PR, but would assume we will be presenting here again this year. I see some other companies that have mentioned here before listed in this PR.
That is awesome news! It is great to see institutions finally taking positions here. Thanks Ericseb2003 for finding and sharing this information. I appreciate it!
I think the purchase was after 3/31/2015, since it is was never listed as a new position at the Nasdaq site for that date:
http://www.nasdaq.com/quotes/institutional-portfolio/ci-investments-inc-97939/new?sortname=companyname&sorttype=0
NYSE halts trading due to 'technical' issue
Other U.S. exchanges operate normally
http://finance.yahoo.com/news/nyse-halts-trading-due-to--technical--issue-164025397.html#
I can agree with that. Collapse/crash will not happen over this. A prolonged strong Dollar caused by a weak Euro though could hurt earnings for those companies that do business overseas.
In theory market Sectors should perform differently.
Underperform sectors:
Tech, Banks, International consumer goods, high yield bonds, Oil/gas
Overperform sectors:
Health Care, Utilities, domestic consumer goods, treasury bonds
While market sentiment could effect CTIX SP, a stronger dollar in itself should not effect CTIX in a negative way.
Here is a prediction that you should Love: Markets get clowned tomorrow.
Dow Futures down 250. Hopefully tomorrow CTIX can fight the tide.
Greece shuts banks in bid to prevent collapse
http://money.cnn.com/2015/06/28/news/economy/greece-banks-ecb/index.html
ECB cuts off new money to Greece
Banks in Greece will not open on Monday as officials scrambled to prevent the country's financial system from collapsing in panic.
Account holders will face tough limits on what they can withdraw from ATMs, and the stock exchange will reportedly be shut.
The measures were announced Sunday as Greece slid rapidly toward default and exit from the eurozone.
European leaders are now facing one of the worst moments in the history of the euro. President Obama called German Chancellor Angela Merkel on Sunday, and the two agreed to take all steps to try to resolve the crisis.
The trigger for the rapid escalation in the crisis was the Greek government's decision late Friday to pull its negotiators out of bailout talks.
Prime Minister Alexis Tsipras slammed a draft proposal from Europe and the International Monetary Fund, and said he would put it to the Greek people in a referendum on July 5.
Since then, European officials have been focusing their efforts on how to limit the damage.
The European Central Bank said Sunday it would provide no new emergency support to Greek banks.
It was forced to act because without a bailout in place, Greece is heading for default as early as Tuesday, and may ultimately have to leave the euro.
The curbs on banking imposed by Greece on Sunday are known as capital controls, which are used only at times of extreme stress in a banking system.
Greek officials did not provide details of the capital controls, nor did they say how long banks would be closed. Greek media reported Sunday that the banks could stay shut for a week and that daily withdrawals would be limited to 60 euros, or about $67.
The country's banks have been bleeding billions of euros for months, even before the country's debt crisis took a dramatic turn for the worse this weekend, leading to long lines at ATMs in Athens.
Tourists should still have access to cash. The Greek government said in a statement that visitors are not subject to the capital controls, and tourists should be able to withdraw money using debt and credit cards issued in their home countries.
Greece faces a critical deadline on Tuesday, when it must make a loan payment to the IMF. Greece looks almost certain to default on that payment.
An extended bank shutdown and tough capital controls will likely wreak further havoc on the Greek economy by scaring away tourists and chilling commercial activity.
And with Greece unable to borrow from financial markets, and apparently unwilling to strike a deal with the only institutions prepared to lend it money, it will find itself sliding rapidly towards exit from the euro.
The FDA meeting is in the next two business days, or has already happened. If this is your biggest worry, then Leo must be doing an outstanding job.
You have that right! Got to believe we see new highs before the EOY. GLTU!
"I think are time is coming "